Katherine Baysinger, MD
Colon & Rectal Surgery · Augusta, GANPI 1992066161
Payments from drug & device makers
What this record shows
This record is dominated by education: $13,250 of the $16,302 with a category attached, or 81.3%. Intuitive Surgical accounts for 93.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $9,148 and has fallen 98.6% since, to $128 in 2025.
Across 50 payments — averaging $326.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$15K
- Medtronic$755
- Pacira Pharmaceuticals Incorporated$187
- Shire North American Group Inc$34
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$34
- Takeda Pharmaceuticals U.S.A., Inc.$20
- plus $47 from 3 others
What the payments were for
- Travel & lodging$1,0366%
- Food & beverage$2,00012%
- Education$13,25081%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 24 | $15,225 |
| Medtronic(2 entities) | 14 | $755 |
| Pacira Pharmaceuticals Incorporated | 4 | $187 |
| Shire North American Group Inc | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$9,000
- Da Vinci Surgical System$5,993
- GI Genius$135
- INTERSTIM$125
- EXPAREL$122
- Sonicision$114
How this compares
$16,302 in reported general payments places this provider in the 75th percentile of 66 colon & rectal surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 42 | $253 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $141 |
| Metronidazole | 45 | $101 |
| Oxycodone Hcl | 13 | $41 |
| Ondansetron Hcl | 37 | $29 |
| Gabapentin | 27 | $18 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Augusta
- Ankur GoelAugusta$19K
- Nathalie Mantilla FarfanAugusta$17K
- Salim AmraniAugusta$8K
- Barry JenkinsAugusta$3K
- John CheapeAugusta$2K
- Mallory LawrenceAugusta$707
- David ArmstrongLawrenceville$1.2M
- Jeffrey CohenMarietta$663K
- Erin King-MullinsMacon$119K
- Jay SinghRoswell$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.